Report of Mail Order Transactions

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
1117-0033 Supporting Statement.docx	Supporting Statement A	Uploaded 2019-05-21	Available
1117-0033 30-Day Notice.pdf	Supplementary Document	Uploaded 2019-05-21	Available
1117-0033 60-Day Notice.pdf	Supplementary Document	Uploaded 2019-05-06	Available
Mail Order e-Report.xls	Supplementary Document	Uploaded 2019-05-16	Available
21 USC 830.pdf	Supplementary Document	Uploaded 2019-05-06	Available

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
12336	Report of Mail Order Transactions		Modified

ICR Details

OMB Control No: 1117-0033	ICR Reference No: 201905-1117-002
Status: Active	Previous ICR Reference No: 201905-1117-001
Agency/Subagency: DOJ/DEA	Agency Tracking No:
Title: Report of Mail Order Transactions
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 07/02/2019
	Date Received in OIRA: 05/21/2019
Terms of Clearance:

table that charts list comparision

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	07/31/2022	36 Months From Approved	07/31/2019
Responses	108	0	98
Time Burden (Hours)	108	0	32
Cost Burden (Dollars)	6,772	0	2,596

---

Abstract: The Drug Enforcement Administration collects information regarding mail order transactions conducted between a person regulated by the agency and a nonregulated person (that is, someone who does not further distribute the product) involving the chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. Transactions must use, or attempt to use, the United States Postal Service or any private or commercial carrier. This collection of information is mandated by 21 U.S.C. 830(b)(3), and permits the agency to monitor the distribution of ephedrine, pseudoephedrine and phenylpropanolamine, chemicals which are subject to diversion for the illicit manufacture of methamphetamine.

---

Authorizing Statute(s): US Code: 21 USC 830(b)(3) Name of Law: Controlled Substances Act
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	84 FR 9137	03/13/2019
30-day Notice:	Federal Register Citation:	Citation Date:
	84 FR 23069	05/21/2019
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

table that charts list of burden

IC Title	Form No.	Form Name
Report of Mail Order Transactions

---

ICR Summary of Burden

table that charts list of burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	108	98	0	10	0	0
Annual Time Burden (Hours)	108	32	0	76	0	0
Annual Cost Burden (Dollars)	6,772	2,596	0	4,176	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: Changes to the annual responses reflect normal changes in registrant population and activity. The larger changes in annual burden hours and burden dollars reflect an adjustment to the estimated burden per response. There have been no statutory or regulatory changes affecting this information collection.

---

Annual Cost to Federal Government: $8,808

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 05/21/2019

---